{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:26:36Z","timestamp":1783578396017,"version":"3.55.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Bristol-Myers-Squibb"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The incidence of anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) shows disparate results due to variable classification criteria and heterogeneous population series. We aimed to estimate the incidence of AAV in a well-defined population with standardized classification criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a population-based study of AAV patients diagnosed from January 2000 to December 2023 in Cantabria, northern Spain. Patients were classified according to ACR\/EULAR 2022 into granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), or unclassified vasculitis if the criteria were not met. Eosinophilic granulomatosis with polyangiitis patients were not included. The annual incidence rates were estimated by cases over 1\u2009000\u2009000 (106) (95% CI) including overall AVV, type of AAV, sex and year of diagnosis. A literature review was also performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 152 patients [80M\/72F; mean age 70.6\u2009(13.18)\u2009years]. They were classified as MPA (67; 44%), GPA (64; 42.2%), and unclassified vasculitis (21; 13.8%). Annual incidence was 13.4 (95% CI: 10, 16.8)\/106 [male 14.5 (95% CI: 10.5, 18.5); female 12.1 (95% CI: 8.7, 15.6)]. The Annual incidence of MPA was 5.9 (95% CI: 4, 7.8)\/106 and GPA 5.6 (95% CI: 3.9, 7.3)\/106. The mean annual incidence increased from 6.1 (95% CI: 4.5, 7.7)\/106 to 16.5 (595% CI: .6, 27.4)\/106 in the last 3\u2009years, particularly in GPA from 2.3 (95% CI: 0.3, 4.9)\/106 to 8.2 (95% CI: 2, 14.5)\/106. The prevalence of AAV was 184.7 (95% CI: 181, 188)\/106.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>During a 20-year period we found that the incidence of AAV (GPA and MPA) in northern Spain was higher than in southern Spain, but lower than northern European countries. An increase in the incidence was observed in the last years.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae413","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:51:20Z","timestamp":1723006280000},"page":"1999-2007","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology of ANCA vasculitis in northern Spain"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-3781","authenticated-orcid":false,"given":"Fabricio","family":"Benavides-Villanueva","sequence":"first","affiliation":[{"name":"Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Herrero-Morant","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Prieto-Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Al Fazazi","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Calvo-R\u00edo","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Renuncio-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Immunology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6938-5084","authenticated-orcid":false,"given":"Adri\u00e1n","family":"Mart\u00edn-Gutierrez","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Amparo","family":"S\u00e1nchez-Lopez","sequence":"additional","affiliation":[{"name":"Dermatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Poo-Fernandez","sequence":"additional","affiliation":[{"name":"Pneumology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Escagedo-Cagigas","sequence":"additional","affiliation":[{"name":"Nephrology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Rodr\u00edguez-Vidriales","sequence":"additional","affiliation":[{"name":"Dermatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2344-2285","authenticated-orcid":false,"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[{"name":"Rheumatology, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL , Santander,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"2025040212110093000_keae413-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025040212110093000_keae413-B2","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An update on the epidemiology of ANCA-associated vasculitis","volume":"59","author":"Mohammad","year":"2020","journal-title":"Rheumatology (United Kingdom)"},{"key":"2025040212110093000_keae413-B3","first-page":"168","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"17","author":"Stone","year":"2010","journal-title":"Journal fur Mineralstoffwechsel"},{"key":"2025040212110093000_keae413-B4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"New Engl J Med"},{"key":"2025040212110093000_keae413-B5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the Treatment of ANCA-Associated Vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"New Engl J Med"},{"key":"2025040212110093000_keae413-B6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2025040212110093000_keae413-B7","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/rheumatology\/kew232","article-title":"Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population","volume":"55","author":"Pearce","year":"2016","journal-title":"Rheumatology (United Kingdom)"},{"key":"2025040212110093000_keae413-B8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener\u2019s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology"},{"key":"2025040212110093000_keae413-B9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3349\/ymj.2022.0435","article-title":"Comparison of the 2022 ACR\/EULAR classification criteria for antineutrophil cytoplasmic antibody-associated vasculitis with previous criteria","volume":"64","author":"Pyo","year":"2023","journal-title":"Yonsei Med J"},{"key":"2025040212110093000_keae413-B10","first-page":"409","author":"Panagiotakis","year":"2009"},{"key":"2025040212110093000_keae413-B11","first-page":"S","article-title":"Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies","volume":"33","author":"Romero-G\u00f3mez","year":"2015","journal-title":"Clinical and Experimental Rheumatology"},{"key":"2025040212110093000_keae413-B12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.semarthrit.2014.05.005","article-title":"Epidemiology of granulomatosis with polyangiitis (Wegener\u2019s granulomatosis) in Northern Italy: a 15-year population-based study","volume":"44","author":"Catanoso","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212110093000_keae413-B13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","article-title":"2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for microscopic polyangiitis","volume":"81","author":"Suppiah","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025040212110093000_keae413-B14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025040212110093000_keae413-B15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis and Rheumatology"},{"key":"2025040212110093000_keae413-B16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/acr.24634","article-title":"2021 American College of Rheumatology\/Vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025040212110093000_keae413-B17","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1093\/rheumatology\/keaa924","article-title":"New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study","volume":"60","author":"Hellmich","year":"2021","journal-title":"Rheumatology (United Kingdom)"},{"key":"2025040212110093000_keae413-B18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.2004.022335","article-title":"Incidence of primary systemic vasculitides in Vilnius: a university hospital population based study","volume":"64","author":"Dadoniene","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2025040212110093000_keae413-B19","doi-asserted-by":"crossref","first-page":"e003824","DOI":"10.1136\/rmdopen-2023-003824","article-title":"Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register","volume":"10","author":"Fern\u00e1ndez-Lozano","year":"2024","journal-title":"RMD Open"},{"key":"2025040212110093000_keae413-B20","doi-asserted-by":"crossref","first-page":"e004039","DOI":"10.1136\/rmdopen-2023-004039","article-title":"The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population","volume":"10","author":"Lundtoft","year":"2024","journal-title":"RMD Open"},{"key":"2025040212110093000_keae413-B21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s10067-019-04463-y","article-title":"Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: a 15-year study","volume":"38","author":"Pierini","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025040212110093000_keae413-B22","doi-asserted-by":"crossref","first-page":"13080","DOI":"10.1038\/s41598-021-92629-7","article-title":"A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes","volume":"11","author":"Scott","year":"2021","journal-title":"Sci Rep"},{"key":"2025040212110093000_keae413-B23","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/rheumatology\/kez597","article-title":"Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway","volume":"59","author":"Nilsen","year":"2020","journal-title":"Rheumatology (United Kingdom)"},{"key":"2025040212110093000_keae413-B24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10067-016-3232-y","article-title":"The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey","volume":"35","author":"Pamuk","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025040212110093000_keae413-B25","first-page":"1","article-title":"Incidence of Wegener\u2019s granulomatosis in Finland 1981-2000","volume":"26","author":"Takala","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2025040212110093000_keae413-B26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ket440","article-title":"Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany","volume":"53","author":"Herlyn","year":"2014","journal-title":"Rheumatology (United Kingdom)"},{"key":"2025040212110093000_keae413-B27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener\u2019s Granulomatosis, and Churg-Strauss Syndrome in a French Urban Multiethnic Population in 2000: a Capture-Recapture Estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025040212110093000_keae413-B28","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The Epidemiology of Antineutrophil Cytoplasmic Autoantibody\u2013Associated Vasculitis in Olmsted County, Minnesota: a Twenty-Year US Population\u2013Based Study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis and Rheumatology"},{"key":"2025040212110093000_keae413-B29","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/art.40577","article-title":"Epidemiology and Outcomes of Granulomatosis With Polyangiitis in Pediatric and Working-Age Adult Populations In the United States: analysis of a Large National Claims Database","volume":"70","author":"Panupattanapong","year":"2018","journal-title":"Arthritis and Rheumatology"},{"key":"2025040212110093000_keae413-B30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1445-5994.2008.01672.x","article-title":"Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales","volume":"38","author":"Ormerod","year":"2008","journal-title":"Intern Med J"},{"key":"2025040212110093000_keae413-B31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1445-5994.2008.01694.x","article-title":"Wegener\u2019s granulomatosis: epidemiological and clinical features in a South Australian study","volume":"38","author":"Hissaria","year":"2008","journal-title":"Intern Med J"},{"key":"2025040212110093000_keae413-B32","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatology"},{"key":"2025040212110093000_keae413-B33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.kint.2023.10.009","article-title":"Executive summary of the KDIGO 2024 clinical practice guideline for the management of ANCA\u2013associated vasculitis","volume":"105","author":"Floege","year":"2024","journal-title":"Kidney Int"},{"key":"2025040212110093000_keae413-B34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025040212110093000_keae413-B35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/14397595.2014.951113","article-title":"Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis","volume":"25","author":"Hirose","year":"2015","journal-title":"Mod Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae413\/58802957\/keae413.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1999\/58802957\/keae413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1999\/58802957\/keae413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T17:24:42Z","timestamp":1743614682000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/1999\/7728461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,6]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae413","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,8,6]]}}}